An Analytical Pill
Measuring gaseous biomarkers to help diagnose and monitor gut disorders.
Luke Turner | | Quick Read
Digestive disorders are common, and their symptoms are often incontrovertible–certainly to the tens ofmillions of patients worldwide who suffer from them. Diagnosis, however, is rarely so clear, which iswhy nearly one-third of all patients with gut disorders are unable to put a name to their condition. But anew device–an electronic capsule that can measure gaseous biomarkers and transmit the informationwirelessly to waiting physicians (1)–may improve upon the accuracy of existing tests.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
- RMIT University, “Diagnostic advance: gas - sensing capsule set to hit market by 2022” (2018). Available at: https://bit.ly/2ChCcCE. Accessed January 2, 2019.